765PPrediction of overall survival with 2nd-line (L2OS) chemotherapy (CT) in patients with advanced biliary tract cancer (aBTC): AGEO CT2BIL cohort update and international multicenter external validations. (23rd October 2018) - Neuzillet, C; Casadei Gardini, A; Brieau, B; Vivaldi, C; Smolenschi, C; Brandi, G; Tougeron, D; Filippi, R; Vienot, A; Silvestris, N; Pointet, A-L; Murgioni, S; et al.